CBD stones. Calculus of gallbladder with acute cholecystitis
Conditions
Interventions
Intervention 1: Intervention group: Common bile duct stenting with Ursodeoxycholic Acid capsule, KoushanPharmed company, 300 mg, oral, once daily, for two months. Intervention 2: Control group: Common
Sponsors
Ghoum University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Common bile duct stone with a diameter greater than 15 mm More than 3 stones in common bile duct
Exclusion criteria
Exclusion criteria: History of recent surgery on bile ducts History of gasterectomy History of duodenal stricture Patients who do not fill the informed concept form
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Common bile duct clearing. Timepoint: 2 months after CBD stenting. Method of measurement: By endoscopic retrograde cholangiopancreatography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Chollangitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: According to Charcot's triad including abdominal pain, serum bilirubin measurement and core body temperature measurement.;Pancreatitis. Timepoint: After endoscopic retrograde cholangiopancreatography. Method of measurement: Serum amylase level measurement.;Reduction in stones size. Timepoint: Two months after common bile duct stenting. Method of measurement: By fluoroscopy during endoscopic retrograde cholangiopancreatography.;Reduction in common bile duct (CBD) stone number. Timepoint: Two months after CBD stenting. Method of measurement: By endoscopic retrograde cholangiopancreatography. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAhmad Hormati
Ghoum University of Medical Sciences
Outcome results
None listed